| Literature DB >> 34064856 |
Pauline Le Faouder1, Julia Soullier1, Marie Tremblay-Franco2, Anthony Tournadre1, Jean-François Martin2, Yann Guitton3, Caroline Carlé4, Sylvie Caspar-Bauguil5, Pierre-Damien Denechaud5, Justine Bertrand-Michel1.
Abstract
Lipids are essential cellular constituents that have many critical roles in physiological functions. They are notably involved in energy storage and cell signaling as second messengers, and they are major constituents of cell membranes, including lipid rafts. As a consequence, they are implicated in a large number of heterogeneous diseases, such as cancer, diabetes, neurological disorders, and inherited metabolic diseases. Due to the high structural diversity and complexity of lipid species, the presence of isomeric and isobaric lipid species, and their occurrence at a large concentration scale, a complete lipidomic profiling of biological matrices remains challenging, especially in clinical contexts. Using supercritical fluid chromatography coupled with high-resolution mass spectrometry, we have developed and validated an untargeted lipidomic approach to the profiling of plasma and blood. Moreover, we have tested the technique using the Dry Blood Spot (DBS) method and found that it allows for the easy collection of blood for analysis. To develop the method, we performed the optimization of the separation and detection of lipid species on pure standards, reference human plasma (SRM1950), whole blood, and DBS. These analyses allowed an in-house lipid data bank to be built. Using the MS-Dial software, we developed an automatic process for the relative quantification of around 500 lipids species belonging to the 6 main classes of lipids (including phospholipids, sphingolipids, free fatty acids, sterols, and fatty acyl-carnitines). Then, we compared the method using the published data for SRM 1950 and a mouse blood sample, along with another sample of the same blood collected using the DBS method. In this study, we provided a method for blood lipidomic profiling that can be used for the easy sampling of dry blood spots.Entities:
Keywords: Dry Blood Spot 4; Lipidomic 1; Plasma 3; Supercritical Fluids Chromatography 3
Year: 2021 PMID: 34064856 PMCID: PMC8151068 DOI: 10.3390/metabo11050305
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 1(A) Total ion chromatogram (TIC) of internal standards mixture in positive (up) and negative (down) ionization mode. (B) Extracted ion chromatogram (EIC) for each internal standards plus free cholesterol and AcylCarnitine: CE 17:0; TG(17:0/17:1/17:0) (d5); DG(12:0/12:0); Cholesterol; Cer(d18:1/12:0); FA 17:0; GlcCer(d18:1/12:0); SM(d18:1/12:0); CAR 12:0; LPC 11:0; PE(12:0/12:0); LacCer(d18:1/12:0); LPE 13:0; PG(12:0/12:0); PI(15:0/18:1)(d7); PS(12:0/12:0) detected either in the positive (ESI+) or in the negative (ESI-) ionization mo.
Chromatographic and mass spectrometry characterisation with theorical (Th) and experimental (Exp) masses with the m/z of daughter (daug) ion and their retention time (RT) for internal standard and few molecular species.
| Lipid Class | Species | RT (min) | Adduct | Mass Dev (ppm) | Mass Dev (ppm) | Structure of Daug Ion | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Choesteryl ester | CE 17:0 | 0.94 | [M+Na]+ | 661.5886 | 661.5894 | 1.2 | no frag | |||
| Free cholesterol | Chol | 2.4 | [(M+H)-H2O]+ | 369.3522 | 369.3516 | −1.6 | 147.1152 | 147.1138 | −9.5 | C11H15+ (ring A and B) |
| Triglycerides | TG(17:0-17:1-17:0) (d5) | 1.05 | [M+NH4]+ | 869.8320 | 869.8329 | 1.0 | 582.5522 | 582.5496 | −4.5 | [(M+H)-FA]+ |
| TG 46:0 | 1.04 | [M+NH4]+ | 796.7406 | 796.7389 | −2.2 | 523.4724 | 523.4721 | −0.6 | [(M+H)-FA]+ | |
| Diglycerides | DG(12:0/12:0) | 2.19 | [(M+H)-H2O]+ | 439.3789 | 439.3782 | −1.6 | 183.1751 | 183.1748 | −1.6 | [(FA+H)-H2O]+ |
| DG 32:0 | 2.33 | [(M+H)-H2O]+ | 551.5043 | 551.5034 | −1.6 | 239.2376 | 239.2375 | −0.4 | [(FA+H)-H2O]+ | |
| Free fatty acid | FA 17:0 | 3.01 | [M-H]− | 269.2494 | 269.2486 | −3.0 | no frag | |||
| Ceramides | Cer(d18:1/12:0) | 3.19 | [(M+H)-H2O]+ | 464.4469 | 464.4462 | −1.5 | 264.2642 | 264.2682 | 15.1 | [(Sphingosine+H)-2H2O]+ |
| Cer(d18:1/24:0) | 3.27 | [(M+H)-H2O]+ | 632.6313 | 632.6340 | 4.3 | 264.2642 | 264.2682 | 15.1 | [(Sphingosine+H)-2H2O]+ | |
| Phosphatidylcholine | PC(13:0/13:0) | 4.36 | [M+H]+ | 650.4772 | 650.4755 | −2.6 | 184.072 | 184.0726 | 3.3 | phosphocholine ion |
| PC(16:0/18:1) | 4.34 | [M+H]+ | 760.5847 | 760.5851 | 0.5 | 184.072 | 184.0726 | 3.3 | phosphocholine ion | |
| Mono Hexosyl Ceramide | GlcCer(d18:1/12:0) | 4.58 | [(M+H)-H2O]+ | 626.4973 | 626.4990 | 2.7 | 264.2673 | 264.2682 | 3.4 | [(Sphingosine+H)-2H2O]+ |
| GalCer(d18:1/16:0) | 4.52 | [M+H]+ | 700.5751 | 700.5722 | −4.1 | 264.2707 | 264.2682 | −9.5 | [(Sphingosine+H)-2H2O]+ | |
| Sphingomyelin | SM(d18:1/12:0) | 4.68 | [M+H]+ | 647.5108 | 647.5123 | 2.2 | 184.072 | 184.0726 | 3.3 | phosphocholine ion |
| SM(d18:1/18:0) | 4.66 | [M+H]+ | 731.6033 | 731.6062 | 3.9 | 184.072 | 184.0726 | 3.3 | phosphocholine ion | |
| Fatty AcylCarnitine | CAR 12:0 | 4.78 | [M+H]+ | 344.2791 | 344.2795 | 1.2 | 183.1752 | 183.1748 | −2.2 | [(FA+H)-H2O]+ |
| Lysophosphatidylcholine | LPC 11:0 | 4.93 | [M+H]+ | 426.2642 | 426.2615 | −6.3 | 184.072 | 184.0726 | 3.3 | phosphocholine ion |
| LPC 20:0 | 4.83 | [M+H]+ | 552.4035 | 552.4024 | −2.1 | 184.072 | 184.0726 | 3.3 | phosphocholine ion | |
| Phosphatidylethanolamine | PE(12:0/12:0) | 5.21 | [M+H]+ | 580.3982 | 580.3973 | −1.6 | 439.3797 | 439.3782 | −3.4 | [(M+H)-phosphoethanolamine -H2O]+ |
| PE(16:0/16:0) | 5.29 | [M+H]+ | 692.5219 | 692.5225 | 0.9 | 551.5028 | 551.5034 | 1.1 | [(M+H)-phosphoethanolamine -H2O]+ | |
| Di Hexosyl Ceramide | LacCer(d18:1/12:0) | 5.54 | [M+H]+ | 806.5635 | 806.5624 | −1.3 | 264.2707 | 264.2682 | −9.5 | [(Sphingosine+H)-2H2O]+ |
| Lysophosphatidylethanolamine | LPE 13:0 | 6.21 | [M+H]+ | 412.2485 | 412.2459 | −6.4 | 271.2288 | 271.2268 | −7.4 | [(M-H)-ethanolamine]− |
| Phosphatidylglycerol | PG(12:0/12:0) | 6.6 | [M-H]− | 609.3776 | 609.3773 | −0.5 | 199.1721 | 199.1704 | −8.5 | RCOO− |
| Phosphatidylinositol | PI(15:0/18:1) (d7) | 7.84 | [M-H]− | 828.5634 | 828.5625 | −1.1 | 288.2911 | 288.2919 | 2.8 | RCOO− |
| PI(18:1/18:1) | 7.89 | [M-H]− | 861.5508 | 861.5499 | −1.0 | 281.2503 | 281.2486 | −6.0 | RCOO− | |
| Phosphatidylserine | PS(12:0/12:0) | 8.25 | [M+H]+ | 622.3727 | 622.3726 | −0.2 | 535.3327 | 535.3405 | 14.6 | [(M-H)-serine]− |
| PS(18:0/18:0) | 7.92 | [M-H]− | 790.5517 | 790.5604 | 11.0 | 703.5201 | 703.5283 | 11.7 | [(M-H)-serine]− |
Evaluation of the repeatability, retention time variation, and linearity (from 250 to 250,000 pg µL−1) of the 15 internal standards, representing the six lipid categories.
| Metabolites | Repeatability (RSD, %) | Retention Time Variation (RSD, %) | Linearity r² | linearity (pg/µL) |
|---|---|---|---|---|
| Cholesterol | 2.6 | 0.4 | 0.997 | 3906.25–250,000 |
| CE 17:0 | 41.1 | 1.3 | 0.94 | 250–1953 |
| DG(12:0/12:0) | 4.2 | 0.7 | 0.98 | 250–3906 |
| TG(17:0/17:1/17:0d5) | 6.1 | 1.3 | 0.99 | 250–7813 |
| Cer(d18:1/12:0) | 13.4 | 0.2 | 0.99 | 250–7813 |
| LPC 11:0 | 11.0 | 0.2 | 0.97 | 250–31,250 |
| PC(13:0/13:0) | 5.4 | 0.0 | 0.99 | 250–31,250 |
| SM(d18:1/12:0) | 8.2 | 0.2 | 0.99 | 250–31,250 |
| GlcCer(d18:1/12:0) | 6.7 | 0.1 | 0.99 | 250–31,250 |
| CAR 12:0 | 27.0 | 0.0 | 0.966 | 250–31,250 |
| FA 17:0 | 23.6 | 0.0 | 0.99 | 250–31,250 |
| LacCer(d18:1/12:0) | 2.2 | 0.3 | 0.99 | 250–62,500 |
| PE(12:0/12:0) | 6.0 | 0.2 | 0.99 | 250–125,000 |
| LPE 13:0 | 0.8 | 0.2 | 0.99 | 250–125,000 |
| PG(12:0/12:0) | 10.0 | 0.1 | 0.99 | 250–125,000 |
| PI(15:0/18:1d7) | 2.1 | 0.1 | 0.99 | 250–125,000 |
| PS(12:0/12:0) | 4.6 | 0.2 | 0.99 | 25–125,000 |
Figure 2Radar chart of % of molecular species per lipid class generated for SRM195 published data (medium blue line) compared to % molecular species per class of lipid generated for data obtained with the new SFC method (dark blue line). (A) Sterol, (B) Triacylglyceride (TG), (C) Free fatty acid (FFA), (D) Ceramides (Cer), (E) Sphingomyelin (SM), (F) Phosphatidylcholine (PC), (G) Phosphatidylethanolamine (PE), (H) Phosphatidylinositol (PI), (I) Lyso-phosphatidylcholine (LPC); (J) Lyso-phosphatidylethanolamine (LPE).
Figure 3(A–M) Box-cum-whisker plots showing relative quantification for main lipid classes detected in Blood (dark blue), the Dry Blood Spot (DBS) T0 extracted the day of the deposit on blotting paper (medium blue) and DBS T3: 3 weeks after the day of deposit (light blue). In the box plots, the boxes denote interquartile ranges, horizontal line inside the box denote the median, and bottom and top boundaries of boxes are 25th and 75th percentiles, respectively. Lower and upper whiskers are 5th and 95th percentiles, respectively. (N) Histogram of % of lipid classes within the total lipids computed for Blood, Dry Blood Spot (DBS) T0 and Dry Blood Spot (DBS) T3 samples.
Figure 4Relative quantities (in %) of each molecular species within each class of whole blood extract (dark blue), Dry Blood Spot (DBS) T0 extracted the day of the collection (medium blue) and Dry Blood Spot (DBS)T3 extracted 3 weeks after collection (light blue) of (A) Ceramide; (B) Lysophosphtidylcholine (LPC); (C) Phosphatidylcholine (PC).